Literature DB >> 2884057

Excessive helper T-cell function in patients with idiopathic pulmonary fibrosis: correlation with disease activity.

M K Cathcart, L I Emdur, K Ahtiala-Stewart, M Ahmad.   

Abstract

Peripheral blood T lymphocytes from patients with idiopathic pulmonary fibrosis and matched normal controls were examined for their helper function in an in vitro antibody synthesis assay. This assay measures the dose-related T-cell regulation of antibody production by B cells in the presence of pokeweed mitogen. Eight patients of 14 expressed significantly increased helper T-cell activity, three exhibited no change, and three had depressed helper T-cell function. All of the patients with excessive helper T-cell function had an active neutrophilic alveolitis as determined by bronchoalveolar lavage on the day of study. Five of the 14 patients studied were determined to have a low percentage of neutrophils (less than 10%) in their BAL fluid. None of these were found to express excessive helper T-cell function; in fact three of the five had depressed helper T-cell function. No correlation between steroid therapy or smoking history and the expression of excessive helper function was observed. None of the peripheral blood T-cells from IPF patients were actively producing IL-2 in vitro without further stimulation, providing evidence against constitutive production in vivo. T cells were also examined for their ability to produce lymphokines promoting fibroblast proliferation. Enhanced stimulation of fibroblast proliferation was shown to positively correlate with disease activity as determined by the degree of neutrophilic alveolitis (r = 0.68). The significant correlation between neutrophilic alveolitis and excessive helper T-cell function observed here suggests that altered systemic immunoregulation accompanies local inflammation. The further participation of patient T cells in promoting fibroblast proliferation may contribute to the development of fibrosis, or to the contrary may be an attempt to limit the fibrotic process.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2884057     DOI: 10.1016/0090-1229(87)90148-6

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  4 in total

1.  Quantitative immunohistologic assessment of lymphocyte populations in the pulmonary inflammatory response to intratracheal silica.

Authors:  R K Kumar
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

2.  Effect of lung T lymphocytes on fibroblasts in idiopathic pulmonary fibrosis and extrinsic allergic alveolitis.

Authors:  M Selman; G Gonzalez; M Bravo; J Sullivan-Lopez; C Ramos; M Montano; N Barquin; F Vadillo
Journal:  Thorax       Date:  1990-06       Impact factor: 9.139

3.  Cyclosporin as a treatment for interstitial lung disease of unknown aetiology.

Authors:  J A Moolman; P G Bardin; D J Rossouw; J R Joubert
Journal:  Thorax       Date:  1991-08       Impact factor: 9.139

Review 4.  New perspectives on basic mechanisms in lung disease. 1. Lung injury, inflammatory mediators, and fibroblast activation in fibrosing alveolitis.

Authors:  M N Sheppard; N K Harrison
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.